Intermediates Product Data

Anti-Tumor category

Source product names, CAS numbers, remarks, and molecular structure images have been preserved from the original page.

Back to Intermediates Request enquiry
Anti-Tumor category category image

Preserved table

Anti-Tumor category products

Use search to quickly find a product name, CAS number, remark, or structure-related row.

NameCAS NoMolecular structure 






Gefitinib Intermediates

3,4-Dihydro-7-methoxy-4-oxoquinazolin-6-yl acetate179688-53-0Molecular structure
7-Methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one199327-61-2Molecular structure
2-Amino-4-methoxy-5-(3-morpholinopropoxy)benzonitrile675126-27-9Molecular structure
N-(3-Chloropropyl)morpholine7357-67-7Molecular structure
3-Ethynyl aniline or (3-aminophenylacetylene)54060-30-9Molecular structure


Erlotinib Intermediates 

6,7-Bis(2-methoxyethoxy)-4(3H)-quinazolinone179688-29-0Molecular structure
5-Formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid253870-02-9Molecular structure


Sunitinib Intermediates

5-Fluoro-2-oxindole56341-41-4Molecular structure
3-(trifluoromethyl)-5-(4-methyl-1H-imidazol-1-yl)benzenamine641571-11-1Molecular structure


Nilotinib Intermediates 

4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid ethyl ester641569-97-3Molecular structure
2-Amino-N-(2-chloro-6-methylphenyl)thiazole -5-carboxamide 302964-24-5Molecular structure


Dasatinib Intermediate

3-Chloro-4-(3-fluorobenzyloxy)aniline202197-26-0Molecular structure


Lapatinib Intermediates

6-Iodoquinazolin-4-one16064-08-7Molecular structure
5-Formyl-2-furyl boronic acid(FFBA)27329-70-0Molecular structure
2-Aminoethylmethylsulfone hydrochloride104458-24-4Molecular structure
Imatinib Mesylate220127-57-1 Molecular structure


Imatinib Intermediates 

N-(2-Methyl-5-Nitrophenyl)-4-(Pyridin-3-yl)Pyrimidin-2-Amine152460-09-8Molecular structure
4-(4-Methylpiperazinomethyl)benzoic Acid Dihydrochloride106261-49-8 Molecular structure
N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine152460-10-1Molecular structure
4-(Chloromethyl)-N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)benzamide404844-11-7Molecular structure
4-chloro-N-methylpyridine-2-carboxamide220000-87-3Molecular structure


Sorafenib/Regorafenib

 Intermediate

4-(4-Bromo-2-fluoroanilino)-7-hydroxy-6-methoxyquinazoline196603-96-0Molecular structure


Vandetanib Intermediate 

4-N-(3-chloro-4-fluorophenyl)-7-[(3S)-oxolan-3-yl]oxyquinazoline-4,6-diamine314771-76-1 Molecular structure


Afatinib Intermediate 

S-(+)-3-Hydroxytetrahydofuran86087-23-2Molecular structure
3-Iodo-6-nitroindazole70315-70-7Molecular structure


Axitinib Intermediate 

6-Iodo-1H-indazole261953-36-0Molecular structure
6-Nitroindazole7597-18-4Molecular structure
3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine330786-24-8Molecular structure


Ibrutinib Intermediate 

4-Chloro-7-methoxyquinoline-6-carboxamide417721-36-9Molecular structure


Lenvatinib Intermediate 

(R)-5-bromo-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-2-amine877399-00-3Molecular structure


Crizotinib Intermediates

tert-Butyl 4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]piperidine-1-carboxylate877399-74-1Molecular structure